Passage Bio(PASG)
$4.00+0.22 (+5.82%)
PASG
Passage Bio financials statements
$4.00
At close:+0.22 (+5.82%)
Want to see PASG full AI Analyst Report?
Passage Bio (PASG) Ratios
645 Followers
Passage Bio Ratios
PASG's free cash flow for Q3 2026 was $-4.00M. For the 2026 fiscal year, PASG's free cash flow was increased by $0.00 and operating cash flow was $-4.00M. See a summary of the company’s cash flow.
| Ratios | Dec 25 | Dec 24 | Dec 23 | Dec 22 | Dec 21 |
|---|---|---|---|---|---|
| Liquidity Ratios | |||||
| Current Ratio | 2.07 | 4.07 | 7.22 | 10.74 | 11.02 |
| Quick Ratio | 2.07 | 4.07 | 7.22 | 10.74 | 11.02 |
| Cash Ratio | 2.01 | 1.94 | 1.33 | 1.89 | 4.37 |
| Solvency Ratio | -1.03 | -1.50 | -2.50 | -3.14 | -5.05 |
| Operating Cash Flow Ratio | -1.37 | -2.48 | -4.79 | -6.44 | -4.30 |
| Short-Term Operating Cash Flow Coverage | 0.00 | -13.00 | 0.00 | 0.00 | 0.00 |
| Net Current Asset Value | $ 4.24M | $ 37.66M | $ 78.70M | $ 154.86M | $ 288.65M |
| Leverage Ratios | |||||
| Debt-to-Assets Ratio | 0.39 | 0.25 | 0.17 | 0.11 | 0.00 |
| Debt-to-Equity Ratio | 1.28 | 0.42 | 0.24 | 0.13 | 0.00 |
| Debt-to-Capital Ratio | 0.56 | 0.29 | 0.19 | 0.12 | 0.00 |
| Long-Term Debt-to-Capital Ratio | 0.52 | 0.00 | 0.00 | 0.00 | 0.00 |
| Financial Leverage Ratio | 3.32 | 1.67 | 1.35 | 1.21 | 1.11 |
| Debt Service Coverage Ratio | 0.00 | -16.83 | 0.00 | 0.00 | 0.00 |
| Interest Coverage Ratio | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Debt to Market Cap | 0.55 | 0.11 | 0.00 | 0.00 | 0.00 |
| Interest Debt Per Share | 7.57 | 8.44 | 9.61 | 9.96 | 0.00 |
| Net Debt to EBITDA | 0.50 | 0.19 | -0.05 | 0.06 | 0.73 |
| Profitability Margins | |||||
| Gross Profit Margin | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| EBIT Margin | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| EBITDA Margin | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Operating Profit Margin | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Pretax Profit Margin | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Net Profit Margin | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Continuous Operations Profit Margin | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Net Income Per EBT | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% |
| EBT Per EBIT | 105.49% | 92.00% | 101.92% | 98.36% | 99.82% |
| Return on Assets (ROA) | -73.09% | -63.24% | -67.80% | -55.89% | -52.21% |
| Return on Equity (ROE) | -242.72% | -105.72% | -91.71% | -67.60% | -58.18% |
| Return on Capital Employed (ROCE) | -110.08% | -84.77% | -74.61% | -61.45% | -57.05% |
| Return on Invested Capital (ROIC) | -100.90% | -81.16% | -72.79% | -60.57% | -57.05% |
| Return on Tangible Assets | -73.09% | -63.24% | -67.80% | -55.89% | -52.21% |
| Earnings Yield | -121.59% | -189.10% | -184.59% | -181.23% | -54.73% |
| Efficiency Ratios | |||||
| Receivables Turnover | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Payables Turnover | 0.65 | 0.00 | 2.87 | 0.00 | 0.00 |
| Inventory Turnover | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Fixed Asset Turnover | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Asset Turnover | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Working Capital Turnover Ratio | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Cash Conversion Cycle | -558.03 | 0.00 | -127.32 | 0.00 | 0.00 |
| Days of Sales Outstanding | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Days of Inventory Outstanding | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Days of Payables Outstanding | 558.03 | 0.00 | 127.32 | 0.00 | 0.00 |
| Operating Cycle | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Cash Flow Ratios | |||||
| Operating Cash Flow Per Share | -9.93 | -15.88 | -28.59 | -43.44 | -47.57 |
| Free Cash Flow Per Share | -9.93 | -15.89 | -28.65 | -45.37 | -57.18 |
| Dividend Paid and CapEx Coverage Ratio | 0.00 | -1410.47 | -536.05 | -22.41 | -4.95 |
| Capital Expenditure Coverage Ratio | 0.00 | -1410.47 | -536.05 | -22.41 | -4.95 |
| Operating Cash Flow Coverage Ratio | -1.31 | -1.88 | -2.98 | -4.36 | 0.00 |
| Operating Cash Flow to Sales Ratio | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Free Cash Flow Yield | -84.16% | -140.12% | -141.81% | -164.40% | -45.03% |
| Valuation Ratios | |||||
| Price-to-Earnings (P/E) Ratio | -0.82 | -0.53 | -0.54 | -0.55 | -1.83 |
| Price-to-Sales (P/S) Ratio | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Price-to-Book (P/B) Ratio | 2.00 | 0.56 | 0.50 | 0.37 | 1.06 |
| Price-to-Free Cash Flow (P/FCF) Ratio | -1.19 | -0.71 | -0.71 | -0.61 | -2.22 |
| Price-to-Operating Cash Flow Ratio | -1.19 | -0.71 | -0.71 | -0.64 | -2.67 |
| Price-to-Earnings Growth (PEG) Ratio | 0.02 | 0.01 | 0.02 | 0.02 | -0.09 |
| Enterprise Value Multiple | -0.34 | -0.36 | -0.61 | -0.51 | -1.19 |
| Enterprise Value | 15.15M | 22.15M | 59.88M | 67.62M | 209.77M |
| EV to EBITDA | -0.34 | -0.36 | -0.61 | -0.51 | -1.19 |
| EV to Sales | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| EV to Free Cash Flow | -0.48 | -0.46 | -0.76 | -0.55 | -1.38 |
| EV to Operating Cash Flow | -0.48 | -0.46 | -0.77 | -0.57 | -1.65 |
| Tangible Book Value Per Share | 5.91 | 20.28 | 40.66 | 73.99 | 119.47 |
| Shareholders’ Equity Per Share | 5.91 | 20.28 | 40.66 | 73.99 | 119.47 |
| Tax and Other Ratios | |||||
| Effective Tax Rate | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Revenue Per Share | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Net Income Per Share | -14.35 | -21.44 | -37.29 | -50.02 | -69.51 |
| Tax Burden | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 |
| Interest Burden | 1.00 | 0.99 | 1.00 | 1.01 | 1.04 |
| Research & Development to Revenue | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| SG&A to Revenue | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Stock-Based Compensation to Revenue | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Income Quality | 0.69 | 0.74 | 0.77 | 0.87 | 0.68 |
Currency in USD
